Passive immunization against clostridium difficile disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/02 (2006.01) A61K 39/08 (2006.01)

Patent

CA 2550108

The invention provides active and passive immunization methods for preventing and treating Clostridium Difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also provided by the invention are C. difficile toxoids, C. difficile toxin-neutralizing polyclonal immune globulin, and methods of identifying subjects that produce C. difficile toxin- neutralizing polyclonal immune globulin.

L'invention concerne des méthodes d'immunisation active et passive pour prévenir et traiter l'infection à Clostridium difficile, consistant à administrer par voie percutanée l'immunoglobuline polyclonale neutralisant les toxines de C. difficile, des toxoïdes de C. difficile ou des combinaisons de ceux-ci. Cette invention concerne également des toxoïdes de C. difficile, l'immunoglobuline polyclonale neutralisant les toxines de C. difficile et des méthodes d'identification de patients qui produisent l'immunoglobuline polyclonale neutralisant les toxines de C. difficile.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Passive immunization against clostridium difficile disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Passive immunization against clostridium difficile disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Passive immunization against clostridium difficile disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2065831

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.